$Flexion Therapeutics(FLXN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-032287 Size: 7 KB 网页链接
$Flexion Therapeutics(FLXN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-032291 Size: 5 KB 网页链接
$Flexion Therapeutics(FLXN)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-20-148673 Act: 33 Size: 414 KB 网页链接
$Flexion Therapeutics(FLXN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-20-148678 Act: 34 Size: 428 KB 网页链接
$Flexion Therapeutics(FLXN)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-20-147375 Act: 33 Size: 417 KB 网页链接
$Flexion Therapeutics(FLXN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-20-147274 Act: 34 Size: 9 MB 网页链接
$Flexion Therapeutics(FLXN)$ 8-K Current report, items 1.01, 2.03, 8.01, and 9.01 Accession Number: 0001564590-20-026066 Act: 34 Size: 610 KB 网页链接
$Flexion Therapeutics(FLXN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-028249 Size: 4 KB 网页链接
$Flexion Therapeutics(FLXN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-20-022827 Act: 34 Size: 9 MB 网页链接
$Flexion Therapeutics(FLXN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-20-022824 Act: 34 Size: 2 MB 网页链接